Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder
Yıl: 2013 Cilt: 23 Sayı: 2 Sayfa Aralığı: 190 - 192 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022
Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder
Öz: -
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. Kumra S, Jacobsen LK, Lenane M, Smith A, Lee P, Malanga CJ, Karp BI, et al. Case series: spectrum of neuroleptic- induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 1998;37(2):221-7.
- 2. Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 2006;63(6):679-85.
- 3. Connor DF, Fletcher KE, Wood JS. Neuroleptic-related dyskinesias in children and adolescents. J Clin Psychiatry 2001;62(12):967-74.
- 4. Erdogan A, Karaman MG, Ozdemir E, Yurteri N, Tufan AE, Kurcer MA. Six months of treatment with risperidone may be associated with nonsignificant abnormalities of liver function tests in children and adolescents: a longitudinal, observational study from Turkey. J Child Adolesc Psychopharmacol 2010(5);20:407-13.
- 5. Ugurlu GK, Tufan E, Bilici R, Ugurlu M, Saglam S. Olanzapine induced tardive dyskinesia treated successfully with quetiapine: A case report. Prog Neuropsychopharmacol Biol Psychiatry 2011;35(1):276-7.
- 6. Owens DGC. Tardive dyskinesia. A guide to the ekstrapyramidal side effects of antipsychotic drugs. Cambridge: Cambridge University Press; 1999.p. 166-226.
- 7. Gupta S. New Approaches to the treatment of dopamine blocking agent-induced movement disorders. In Sethi KD (editör). Drug Induced Movement Disorders. New York: Marcel Dekker Inc, 2004.p. 193-208.
- 8. Janicak PG, Beedle D. Neuroleptic-induced tardive dyskinesia. In: Kaplan and Sadock’s Comprehensive Textbook of Psychiatry, Sadock BJ, Sadock VA (editors). 8th Edition. Philadelphia: Lippincott Williams and Wilkins;n2005.p. 2716-7.
- 9. Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, et al. Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry 1992;149(6):773-7.
- 10. Adler LA, Rotrosen J, Edson R, Lavori P, Lohr J, Hitzemann R, et al. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group. Arch Gen Psychiatry 1999;56(9):836-41.
- 11. Soares KV, McGrath JJ. Vitamin E for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2001;(4): CD000209.
- 12. Barak Y, Swarta M, Smair E, Stein D, Weizman A. Vitamin E (μ-tocopherol) in the treatment of tardive dyskinesia: A statistical meta-analysis. Ann Clin Psych 1998;10(3):101-5.
- 13. De Leon ML, Jankovic J. Clinical Features and Management of Classic Tardive Dyskinesia, Tardive Myoclonus, Tardive Tremor and Tardive Tourettism. In Sethi KD (editör). Drug Induced Movement Disorders. New York: Marcel Dekker Inc; 2004.p.77-109.
| APA | TUFAN A, YALUĞ İ, BİLİCİ R (2013). Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder. , 190 - 192. |
| Chicago | TUFAN ALİ EVREN,YALUĞ İrem,BİLİCİ Rabia Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder. (2013): 190 - 192. |
| MLA | TUFAN ALİ EVREN,YALUĞ İrem,BİLİCİ Rabia Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder. , 2013, ss.190 - 192. |
| AMA | TUFAN A,YALUĞ İ,BİLİCİ R Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder. . 2013; 190 - 192. |
| Vancouver | TUFAN A,YALUĞ İ,BİLİCİ R Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder. . 2013; 190 - 192. |
| IEEE | TUFAN A,YALUĞ İ,BİLİCİ R "Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder." , ss.190 - 192, 2013. |
| ISNAD | TUFAN, ALİ EVREN vd. "Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder". (2013), 190-192. |
| APA | TUFAN A, YALUĞ İ, BİLİCİ R (2013). Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder. Klinik Psikofarmakoloji Bülteni, 23(2), 190 - 192. |
| Chicago | TUFAN ALİ EVREN,YALUĞ İrem,BİLİCİ Rabia Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder. Klinik Psikofarmakoloji Bülteni 23, no.2 (2013): 190 - 192. |
| MLA | TUFAN ALİ EVREN,YALUĞ İrem,BİLİCİ Rabia Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder. Klinik Psikofarmakoloji Bülteni, vol.23, no.2, 2013, ss.190 - 192. |
| AMA | TUFAN A,YALUĞ İ,BİLİCİ R Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder. Klinik Psikofarmakoloji Bülteni. 2013; 23(2): 190 - 192. |
| Vancouver | TUFAN A,YALUĞ İ,BİLİCİ R Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder. Klinik Psikofarmakoloji Bülteni. 2013; 23(2): 190 - 192. |
| IEEE | TUFAN A,YALUĞ İ,BİLİCİ R "Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder." Klinik Psikofarmakoloji Bülteni, 23, ss.190 - 192, 2013. |
| ISNAD | TUFAN, ALİ EVREN vd. "Vitamin E treatment for olanzapine induced tardive dyskinesia in an adolescent with Bipolar Disorder". Klinik Psikofarmakoloji Bülteni 23/2 (2013), 190-192. |
